Bronnen:
- Oxnard GR, Hu Y, Mileham KF et al. Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M–Positive Lung Cancer and Acquired Resistance to Osimertinib. JAMA Oncol. Published online August 2, 2018. doi:10.1001/jamaoncol.2018.2969